ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Open Vet J. 2025; 15(6): 2532-2539


Ameliorative effect of spirulina on methotrexate-induced male fertility and oxidative stress in rats

Noran Ibrahim Salah, Reda M. Abd El-Aziz, Sameh Elnabtity, Wageh Sobhy Darwish.



Abstract
Download PDF Cited by 0 ArticlesPost

Background:
Methotrexate is a chemotherapy drug that is used despite having several toxic effects. Spirulina is commonly consumed as a food supplement because of its antioxidant, antiinflammatory, and other beneficial effects.

Aim:
The present study was conducted to investigate the adverse effects of MTX on male sex hormones and subsequently its effects on oxidant/antioxidant status. The ameliorative effects of spirulina against such MTX-induced adverse effects were also evaluated.

Methods:
Forty male rats were randomly divided into four groups: control, spirulina, MTX, and MTX + spirulina groups. The levels of testosterone (free and total), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin hormone were evaluated as biochemical markers of MTX-induced infertility. Malondialdehyde (MDA) and total antioxidant capacity (TAC) levels were assayed in liver tissue as oxidative stress markers.

Results:
The results obtained from the current study showed that Spirulina improved the adverse effects of MTX on testosterone (free and total), LH, FSH, MDA, and TAC.

Conclusions:
The current study indicated that spirulina can be used to ameliorate MTX-induced adverse effects on male infertility and oxidative stress.

Key words: Methotrexate, Spirulina, Infertility, Oxidative stress







Bibliomed Article Statistics

19
28
17
18
17
17
28
27
R
E
A
D
S

24

25

18

8

13

20

19

23
D
O
W
N
L
O
A
D
S
0708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.